Burki TK (2020) Pharmacotherapy for pulmonary arterial hypertension. Lancet Respir Med 8:e81. https://doi.org/10.1016/S2213-2600(20)30394-5
Article CAS PubMed Google Scholar
Chang HC, Guarente L (2014) SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab 25:138–145. https://doi.org/10.1016/j.tem.2013.12.001
Article CAS PubMed Google Scholar
Davis PA, Pagnin E, Dal Maso L, Caielli P, Maiolino G, Fusaro M, Paolo Rossi G, Calò LA (2013) SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension. Hypertens Res 36:873–878. https://doi.org/10.1038/hr.2013.48
Article CAS PubMed Google Scholar
Deng L, Blanco FJ, Stevens H, Lu R, Caudrillier A, McBride M, McClure JD, Grant J, Thomas M, Frid M, Stenmark K, White K, Seto AG, Morrell NW, Bradshaw AC, MacLean MR, Baker AH (2015) Activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension. Circ Res 117:MicroRNA–143. https://doi.org/10.1161/CIRCRESAHA.115.306806
Diao W, Liu G, Shi C, Jiang Y, Li H, Meng J, Shi Y, Chang M, Liu X (2022) Evaluating the effect of circ-Sirt1 on the expression of SIRT1 and its role in pathology of pulmonary hypertension. Cell Transpl 31:9636897221081479. https://doi.org/10.1177/09636897221081479
Du R, Wang T, Lv H, Zou Y, Hou X, Hou N, Zhang P, Li H, Chi G (2022) Shionone-targeted pneumolysin to ameliorate acute lung injury induced by Streptococcus pneumoniae in vivo and in vitro. Molecules 27:6258. https://doi.org/10.3390/molecules27196258
Article CAS PubMed Google Scholar
Dubois M, Delannoy E, Duluc L, Closs E, Li H, Toussaint C, Gadeau AP, Godecke A, Freund-Michel V, Courtois A, Marthan R, Savineau JP, Muller B (2013) Biopterin metabolism and eNOS expression during hypoxic pulmonary hypertension in mice. PLoS ONE 8:e82594. https://doi.org/10.1371/journal.pone.0082594
Article CAS PubMed Google Scholar
Evans CE, Cober ND, Dai Z, Stewart DJ, Zhao YY (2021) Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur Respir J 58:2003957. https://doi.org/10.1183/13993003.03957-2020
Article CAS PubMed Google Scholar
Ferreira AC, Serejo JS, Durans R, Pereira Costa JM, Maciel AWS, Vieira ASM, Dias-Filho CAA, Dias CJ, Bomfim MRQ, Mostarda CT, Brito-Monzani JO (2020) Dose-related effects of resveratrol in different models of pulmonary arterial hypertension: a systematic review. Curr Cardiol Rev 16:231–240. https://doi.org/10.2174/1573403X15666191203110554
Article PubMed PubMed Central Google Scholar
Frank BS, Ivy DD (2020) Pediatric pulmonary arterial hypertension. Pediatr Clin North Am 67:903–921. https://doi.org/10.1016/j.pcl.2020.06.005
He S, Zhu T, Fang Z (2020) The role and regulation of pulmonary artery smooth muscle cells in pulmonary hypertension. Int J Hypertens 2020:1478291. https://doi.org/10.1155/2020/1478291
Article CAS PubMed Google Scholar
Kackstein K, Teren A, Matsumoto Y, Mangner N, Möbius-Winkler S, Linke A, Schuler G, Punkt K, Adams V (2013) Impact of angiotensin II on skeletal muscle metabolism and function in mice: contribution of IGF-1, Sirtuin-1 and PGC-1alpha. Acta Histochem 115:363–370. https://doi.org/10.1016/j.acthis.2012.09.009
Article CAS PubMed Google Scholar
Klouda T, Yuan K (2021) Inflammation in pulmonary arterial hypertension. In: Wang YX (ed) Lung inflammation in health and disease, volume I. Advances in Experimental Medicine and Biology, vol 1303. Springer, Cham. https://doi.org/10.1007/978-3-030-63046-1_19
Kumar P, Nagarajan A, Uchil PD (2018) Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc 2018:469–471. https://doi.org/10.1101/pdb.prot095505.
Mao J, Ma L (2022) Research progress on the mechanism of phenotypic transformation of pulmonary artery smooth muscle cells induced by hypoxia. Zhejiang Da Xue Xue bao Yi xue ban 51:750–757. https://doi.org/10.3724/zdxbyxb-2022-0282
Maron BA, Abman SH, Elliott CG, Frantz RP, Hopper RK, Horn EM, Nicolls MR, Shlobin OA, Shah SJ, Kovacs G, Olschewski H, Rosenzweig EB (2021) Pulmonary arterial hypertension: diagnosis, treatment, and novel advances. Am J Respir Crit Care Med 203:1472–1487. https://doi.org/10.1164/rccm.202012-4317SO
Article CAS PubMed Google Scholar
Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, Irani K (2007) SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 104:14855–14860. https://doi.org/10.1073/pnas.0704329104
Article CAS PubMed Google Scholar
Meloche J, Renard S, Provencher S, Bonnet S (2013) Anti-inflammatory and immunosuppressive agents in PAH. Handb Exp Pharmacol 218:437–476. https://doi.org/10.1007/978-3-642-38664-0_18
Article CAS PubMed Google Scholar
Mirhadi E, Roufogalis BD, Banach M, Barati M, Sahebkar A (2021) Resveratrol: mechanistic and therapeutic perspectives in pulmonary arterial hypertension. Pharmacol Res 163:105287. https://doi.org/10.1016/j.phrs.2020.105287
Article CAS PubMed Google Scholar
Naito H, Iba T, Takakura N (2020) Mechanisms of new blood-vessel formation and proliferative heterogeneity of endothelial cells. Int Immunol 32:295–305. https://doi.org/10.1093/intimm/dxaa008
Article CAS PubMed Google Scholar
Ng TB, Liu F, Lu Y, Cheng CH, Wang Z (2003) Antioxidant activity of compounds from the medicinal herb Aster tataricus. Comp Biochem Physiol C Toxicol Pharmacol 136:109–115. https://doi.org/10.1016/s1532-0456(03)00170-4
Article CAS PubMed Google Scholar
Rosenzweig EB, Abman SH, Adatia I, Beghetti M, Bonnet D, Haworth S, Ivy DD, Berger RMF (2019) Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J 53:1801916. https://doi.org/10.1183/13993003.01916-2018
Article PubMed PubMed Central Google Scholar
Savai R, Pullamsetti SS, Kolbe J, Bieniek E, Voswinckel R, Fink L, Scheed A, Ritter C, Dahal BK, Vater A, Klussmann S, Ghofrani HA, Weissmann N, Klepetko W, Banat GA, Seeger W, Grimminger F, Schermuly RT (2012) Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 186:897–908. https://doi.org/10.1164/rccm.201202-0335OC
Article CAS PubMed Google Scholar
Sawai S, Uchiyama H, Mizuno S, Aoki T, Akashi T, Ayabe S, Takahashi T (2011) Molecular characterization of an oxidosqualene cyclase that yields shionone, a unique tetracyclic triterpene ketone of Aster tataricus. FEBS Lett 585:1031–1036. https://doi.org/10.1016/j.febslet.2011.02.037
Article CAS PubMed Google Scholar
Siques P, Pena E, Brito J, El Alam S (2021) Oxidative stress, kinase activation, and inflammatory pathways involved in effects on smooth muscle cells during pulmonary artery hypertension under hypobaric hypoxia exposure. Front Physiol 12:690341. https://doi.org/10.3389/fphys.2021.690341
Article PubMed PubMed Central Google Scholar
Song Y, Wu Q, Jiang H, Hu A, Xu L, Tan C, Zhang B, Yu R, Qiu Y, Wang X, Yang W (2021) The effect of shionone on sepsis-induced acute lung injury by the ECM1/STAT5/NF-KappaB pathway. Front Pharmacol 12:764247. https://doi.org/10.3389/fphar.2021.764247
Article CAS PubMed Google Scholar
Sturtzel C (2017) Endothelial cells. Adv Exp Med Biol 1003:71–91. https://doi.org/10.1007/978-3-319-57613-8_4
Article CAS PubMed Google Scholar
Thenappan T, Ormiston ML, Ryan JJ, Archer SL (2018) Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ 360:j5492. https://doi.org/10.1136/bmj.j5492
Article PubMed PubMed Central Google Scholar
Vazquez ZGS, Klinger JR (2020) Guidelines for the treatment of pulmonary arterial hypertension. Lung 198:581–596. https://doi.org/10.1007/s00408-020-00375-w
Wang Y, Zhong B, Wu Q, Tong J, Zhu T, Zhang M (2020) Effect of aldosterone on senescence and proliferation inhibition of endothelial progenitor cells induced by sirtuin
留言 (0)